Woman Alleges Merck Failed to Disclose Risks of Fosamax, Rottenstein Law Group Reports
March 13, 2013 06:00 ET | Rottenstein Law Group, LLP
NEW YORK, March 13, 2013 (GLOBE NEWSWIRE) -- The first trial to feature claims that Merck hid the alleged bone-weakening, femur-fracturing side effects of Fosamax began this week.* Christina Su, 67,...
Stryker Hip Replacement Recall News: Rottenstein Law Group Responds to Reports That FDA Issued Warning to Metal-on-Metal Hip Maker
March 12, 2013 14:29 ET | Rottenstein Law Group, LLP
NEW YORK, March 12, 2013 (GLOBE NEWSWIRE) -- Metal-on-metal hip implant maker Stryker announced* this week that it received a warning from the U.S. Food and Drug Administration related to concerns...